ContraBand: the only heart failure medical device that is placed outside the hea...
ContraBand: the only heart failure medical device that is placed outside the heart
Worldwide 26 million people suffer from Congestive Heart Failure (CHF), a chronic condition that worsens with time and leads to staggering healthcare costs and a significant reduction of quality of life. ContraBand is an implantab...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
V-sling
Transcatheter Ventricular Repair Device for treatment of Hea...
9M€
Cerrado
HD4HF
Heart Damper a revolutionary device for Heart Failure
71K€
Cerrado
HIT-LVAD
Understanding blood pressure and vascular haemodynamics in i...
252K€
Cerrado
FLOWMAKER
Saving patients from severe heart failure
19M€
Cerrado
CORolla
CORolla a disruptive spring like metallic device for...
71K€
Cerrado
Información proyecto Contraband
Duración del proyecto: 24 meses
Fecha Inicio: 2022-11-28
Fecha Fin: 2024-11-30
Líder del proyecto
RESTORE MEDICAL LTD
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Worldwide 26 million people suffer from Congestive Heart Failure (CHF), a chronic condition that worsens with time and leads to staggering healthcare costs and a significant reduction of quality of life. ContraBand is an implantable device aiming to restore heart function in patient suffering from left ventricle failure. ContraBand’s benefits include built-in fail-safe for full reversibility of functionality, tremendous ease of use due to its proprietary stеnt-within-a-stеnt design and transcatheter delivery system, and full clinical flexibility to be compatible with pharmacotherapies and other CHF devices. In the project, we will finalise clinical development and introduce ContraBand into clinical routines in Europe. We expect to launch ContraBand in 2024, generate €15M in revenues in 2025 and €60M in 2026. Before market launch, we will create >95 jobs at the company in strategic locations in Europe.